Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faecium
1996
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?
1999
Vulvovaginal candidosis
2007 Standout
Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection
2007
Syndemics and the biosocial conception of health
2017 Standout
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
1998
Wearable biosensors for healthcare monitoring
2019 Standout
Coinfection with Herpes Simplex Virus Type 2 Is Associated with Reduced HIV‐Specific T Cell Responses and Systemic Immune Activation
2008
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Infections in adults undergoing unrelated donor bone marrow transplantation
1999
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Superantigen Shock In Mice With An Inapparent Viral Infection
1994 StandoutNobel
Osteomyelitis
1997 Standout
Optical control of antibacterial activity
2013 StandoutNobel
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
Methicillin-Resistant Staphylococcus aureus
1989 Standout
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
Application of fluoroquinolone pharmacodynamics
2000
Is HIV a Model of Accelerated or Accentuated Aging?
2013
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Fluconazole vs Itraconazole-Flucytosine Association in the Treatment of Esophageal Candidiasis in AIDS Patients
1996
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
2014
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Echinocandin antifungal drugs
2003 Standout
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
1994 StandoutNature
Diet rapidly and reproducibly alters the human gut microbiome
2013 StandoutNature
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both
1989
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
Pathogenesis of HIV-associated cardiovascular complications
2001
Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
1994
Vancomycin-Resistant Enterococcal Infections
2000 Standout
The diagnostic uses of saliva
1990
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
HIV and Aging: Time for a New Paradigm
2010
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Geroscience: Linking Aging to Chronic Disease
2014 Standout
Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV-1 Infection?
2002
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
1999
Assessment and Management of Foot Disease in Patients with Diabetes
1994 Standout
Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease
1988
WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
1989
Extrathymic positive selection of αβ T-cell precursors in nude mice
1992 StandoutNatureNobel
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
IgG subclass-specific antibodies to human cytomegalovirus (HCMV)-induced early antigens
1991
Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
2002 Standout
Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis
1991
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Molecular Ecological Analysis of the Succession and Diversity of Sulfate-Reducing Bacteria in the Mouse Gastrointestinal Tract
2000
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation.
1996 StandoutNobel
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
1992 StandoutScience
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Population Structure and Dynamics of the Western Spotted Frog, Rana p. pretiosa Baird & Girard, in Yellowstone Park, Wyoming
1960
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Antiviral therapy for human immunodeficiency virus infections
1995
The Emergence of Methicillin-Resistant Staphylococcus aureus Infections in United States Hospitals
1982
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
Herpesviruses as Co-Factors of HIV Disease: Case not Proven
1995
The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection
1980
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus
1994
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
Transmission dynamics of HIV infection
1987 Nature
Moraxella, Acinetobacter, and the Mimeae
1973
Coronary Heart Disease in HIV-Infected Individuals
2003
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Invasive Candidiasis
2015 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Ecological Aspects of Amphibian Metamorphosis
1973 StandoutScience
Plant Products as Antimicrobial Agents
1999 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Kinetics of antimicrobial activity
1986
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
1999
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Modeling and analyzing HIV transmission: the effect of contact patterns
1988
Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis.
1987 StandoutNobel
Polyoxometalates in Medicine
1998 Standout
Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
2002
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Guidelines for Treatment of Candidiasis
2004 Standout
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
2000 Standout
Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis
2002
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors
1995
Works of W. Stille being referenced
Defective monocyte to macrophage maturation in human immunodeficiency virus infection
1990
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex
1993
Interventional antimicrobial therapy in febrile neutropenic patients
1994
Decrease of caffeine elimination in man during co-administration of 4-quinolones
1987
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients
1991
Itraconazol‐Suspension in der Behandlung HIV‐infizierter Patienten mit Fluconazol‐resistenter oropharyngealer Candida‐Infektion und Soorösophagitis
1996
Clinical efficacy and safety of teicoplanin
1988
Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia results of a multicenter study
1995
Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies
1996
Fluconazole in the treatment of oropharyngeal candidosis in HIV‐positive patients
1990
Adenylylsulfate reductase in some new sulfate-reducing bacteria
1984
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study.
2000
[METHICILLIN- AND OXACILLIN-RESISTANT STAPHYLOCOCCI].
1964
Mima polymorpha in einem Hirnabsceß bei einem Kriegsverletzten
1963
Syrische Goldhamster als Uberträger von Lymphozytärer Choriomeningitis
1972
Imipenem: The First Thienamycin Antibiotic
1985
Spontanverlauf der LAV/HTLV-III-Infektion: Verlaufsbeobachtungen bei Personen aus AIDS-Risikogruppen
2008
The Nocturnal Amphibian Fauna of the Southern Lake Michigan Beach
1952
Dosis-Wirkungs-Beziehung der Bakterizidie bei E. coli, K. pneumoniae und Staphylococcus aureus
1976
Change of Causative Organisms under Antifungal Treatment in Immunosuppressed Patients with HIV‐Infections
1989
Klinik und Therapie der Enterokokken-Endokarditis
1966
Effect of concentration on bactericidal activity of cefotaxime
1979
[MIMA POLYMORPHA IN A BRAIN ABSCESS IN A WAR-INJURED PERSON].
1963
Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.
1998